These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 9366575)

  • 1. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
    Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
    J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin.
    Zheng B; Clarke JB; Busby WH; Duan C; Clemmons DR
    Endocrinology; 1998 Apr; 139(4):1708-14. PubMed ID: 9528953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells.
    Moralez A; Busby WH; Clemmons D
    Endocrinology; 2003 Jun; 144(6):2489-95. PubMed ID: 12746311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
    Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
    J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions.
    Rees C; Clemmons DR; Horvitz GD; Clarke JB; Busby WH
    Endocrinology; 1998 Oct; 139(10):4182-8. PubMed ID: 9751498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I.
    Zheng B; Duan C; Clemmons DR
    J Biol Chem; 1998 Apr; 273(15):8994-9000. PubMed ID: 9535886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glucose on insulin-like growth factor binding protein-4 proteolysis.
    Jacot TA; Clemmons DR
    Endocrinology; 1998 Jan; 139(1):44-50. PubMed ID: 9421396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
    Cohick WS; Gockerman A; Clemmons DR
    J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells.
    Parker A; Gockerman A; Busby WH; Clemmons DR
    Endocrinology; 1995 Jun; 136(6):2470-6. PubMed ID: 7538463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia.
    Nichols TC; Busby WH; Merricks E; Sipos J; Rowland M; Sitko K; Clemmons DR
    Endocrinology; 2007 Oct; 148(10):5002-10. PubMed ID: 17640990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.
    Parker A; Rees C; Clarke J; Busby WH; Clemmons DR
    Mol Biol Cell; 1998 Sep; 9(9):2383-92. PubMed ID: 9725901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5.
    Rees C; Clemmons DR
    J Cell Biochem; 1998 Dec; 71(3):375-81. PubMed ID: 9831074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta.
    Durham SK; Riggs BL; Conover CA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic degradation of insulin-like growth factor (IGF)-binding protein-3 by porcine ovarian granulosa cells in culture: regulation by IGF-I.
    Grimes RW; Hammond JM
    Endocrinology; 1994 Jan; 134(1):337-43. PubMed ID: 7506209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
    Durham SK; Kiefer MC; Riggs BL; Conover CA
    J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies.
    Conover CA; Kiefer MC; Zapf J
    J Clin Invest; 1993 Mar; 91(3):1129-37. PubMed ID: 7680662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.
    Qin X; Byun D; Strong DD; Baylink DJ; Mohan S
    J Bone Miner Res; 1999 Dec; 14(12):2079-88. PubMed ID: 10620067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions.
    Nam T; Moralez A; Clemmons D
    Endocrinology; 2002 Jan; 143(1):30-6. PubMed ID: 11751588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells.
    Xu Q; Li S; Zhao Y; Maures TJ; Yin P; Duan C
    Circ Res; 2004 Mar; 94(5):E46-54. PubMed ID: 15001525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.